NCT05430646

Brief Summary

BSUS patients were prospectively enrolled in this study, and non-randomly treated with "balloon dilation +CMUS" and "balloon dilation + tandem DJ stent". Perioperative data of the patients were recorded to compare their efficacy and complications, and the ureteral stent symptom questionnaire was used to compare their impact on patients' quality of life. CMUS and tandem DJ stents were removed after ≥3 months of indwelling. After the removal of stents, the patients' serum creatinine and renal pelvis width were followed up to compare their curative effect on BSUS.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2023

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 13, 2022

Completed
11 days until next milestone

First Posted

Study publicly available on registry

June 24, 2022

Completed
6 months until next milestone

Study Start

First participant enrolled

January 1, 2023

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

June 24, 2022

Status Verified

June 1, 2022

Enrollment Period

2 years

First QC Date

June 13, 2022

Last Update Submit

June 18, 2022

Conditions

Keywords

ureteral strictureureteral stentcurative effect

Outcome Measures

Primary Outcomes (5)

  • Postoperative Serum Creatinine (SCr)

    It represents for the renal function change after ureteral stent insertion.

    Postoperative 3-month

  • Serum Creatinine (SCr) after stent removal

    It represents for the curative effect of balloon dilatation and ureteral stent.

    Three-month after stent removal

  • Postoperative Renal pelvic width (RPW)

    It represents for the change of hydronephrosis after ureteral stent insertion.

    Postoperative 3-month

  • Renal pelvic width (RPW) after stent removal

    It represents for the curative effect of balloon dilatation and ureteral stent.

    Three-month after stent removal

  • Ureteral stent symptom questionnaire (USSQ)

    USSQ represents for the quality of life of patients with ureteral stents.

    Postoperative 3-month

Secondary Outcomes (1)

  • Complications

    Postoperative 3-month

Study Arms (2)

CMUS group

EXPERIMENTAL

Balloon dilatation and CMUS insertion were performed in this group.

Device: Covered metal ureteral stents

Tandem DJ stent group

ACTIVE COMPARATOR

Balloon dilatation and Tandem DJ stent insertion were performed in this group.

Device: Tandem DJ stents

Interventions

The CMUS is a fully covered, self-expanding, large caliber metal stent. The stent is made of super-elastic nickel-titanium alloy, which maintain lumen patency via providing long-term direct wall support.

CMUS group

Tandem DJ stents represents for two stents side-by-side, which improves the urine flow by better withstanding the compressive tumoral forces and allowing urine to flow between the stents.

Tandem DJ stent group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • BSUS patients from January 2023 to January 2024 in Peking University People's Hospital, no gender limitation, aged from 18 to 80, Benign ureteral stricture with definite reason (ureteropelvic junction obstruction, ischemic ureter stenosis caused by surgical separation, ureter partial excision anastomosis stricture after operation, ureteral stricture caused by ureteral endoscope surgery, ureteral stenosis caused by impacted ureteral calculi, ureteral anastomotic stricture after urinary flow diversion, ureteral anastomotic stricture after kidney transplantation, retroperitoneal fibrosis, ureteral stricture caused by trauma, idiopathic ureteral stricture), patients can tolerate anesthesia and surgery and obtain informed consent.

You may not qualify if:

  • Patients with hypertonic neurogenic bladder, severe bladder outlet obstruction or bladder capacity less than 50ml, combined with sepsis, incomplete clinical data, failed stent implantation, insufficient indwelling time (\< 3 months), postoperative loss of follow-up.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 13, 2022

First Posted

June 24, 2022

Study Start

January 1, 2023

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

June 24, 2022

Record last verified: 2022-06

Data Sharing

IPD Sharing
Will not share